PE20030098A1 - Capsulas elasticas blandas y composiciones de las mismas - Google Patents

Capsulas elasticas blandas y composiciones de las mismas

Info

Publication number
PE20030098A1
PE20030098A1 PE2002000436A PE2002000436A PE20030098A1 PE 20030098 A1 PE20030098 A1 PE 20030098A1 PE 2002000436 A PE2002000436 A PE 2002000436A PE 2002000436 A PE2002000436 A PE 2002000436A PE 20030098 A1 PE20030098 A1 PE 20030098A1
Authority
PE
Peru
Prior art keywords
alcohol
amino
filler
initial state
agent
Prior art date
Application number
PE2002000436A
Other languages
English (en)
Spanish (es)
Inventor
Alessandro Barbato
Sergio Petriconi
Martin Urch
Roberta Scuppa
Azita Saleki-Gerhardt
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20030098A1 publication Critical patent/PE20030098A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE2002000436A 2001-05-25 2002-05-24 Capsulas elasticas blandas y composiciones de las mismas PE20030098A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86628501A 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
PE20030098A1 true PE20030098A1 (es) 2003-02-12

Family

ID=25347294

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000436A PE20030098A1 (es) 2001-05-25 2002-05-24 Capsulas elasticas blandas y composiciones de las mismas

Country Status (8)

Country Link
EP (1) EP1395249A1 (ja)
JP (1) JP2005508294A (ja)
AR (1) AR034995A1 (ja)
CA (1) CA2448438A1 (ja)
MX (1) MXPA03010771A (ja)
PE (1) PE20030098A1 (ja)
UY (1) UY27306A1 (ja)
WO (1) WO2002096395A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE329579T1 (de) 1999-11-12 2006-07-15 Abbott Lab Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
KR20150021510A (ko) 2012-05-03 2015-03-02 시플라 리미티드 항레트로바이러스 조성물
WO2019130341A1 (en) * 2017-12-26 2019-07-04 Hetero Labs Limited Capsule compositions comprising lopinavir and ritonavir
GB201917252D0 (en) 2019-11-27 2020-01-08 Pharmaceutic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232333B1 (en) * 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
PT1183026E (pt) * 1999-06-04 2006-11-30 Abbott Lab Formulações farmacêuticas melhoradas incluindo ritonavir
US6608198B2 (en) * 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical

Also Published As

Publication number Publication date
JP2005508294A (ja) 2005-03-31
UY27306A1 (es) 2002-12-31
MXPA03010771A (es) 2004-07-01
EP1395249A1 (en) 2004-03-10
AR034995A1 (es) 2004-04-14
CA2448438A1 (en) 2002-12-05
WO2002096395A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
CL2008003491A1 (es) Composicion farmaceutica en solucion que comprende ritonavir, un solvente organico que comprende un acido graso de cadena larga entre un 30-75% en peso total, agua entre 0,4-3,5% en peso total y opcionalmente un surfactante (divisional de la solicitud 1257-00).
PE20100363A1 (es) Composiciones que comprenden nucleosidos
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
BR0015605A (pt) Composição e uso
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
MXPA06008352A (es) Una composicion farmaceutica.
AR024228A1 (es) Una composicion farmaceutica que comprende un sensibilizador de insulina y otro agente antidiabetico
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
AR051340A1 (es) Compuesto de c(4)- metoximetil acil pirrolidina, su uso para preparar un medicamento, formulacion farmaceutica que lo comprende y proceso para prepararlo
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
ECSP045496A (es) "preparaciones acidas de insulina con estabilidad mejorada"
AR049658A2 (es) Ritonavir amorfo, su uso en la fabricacion de un medicamento, composicion farmaceutica, proceso para su preparacion y proceso para la preparacion de la forma polimorfa cristalina i de ritonavir.
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
ECSP034789A (es) Composicion parenteral reconstituible que contiene un inhibidor cox-2 ta
BR0314450A (pt) Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica
DE602004015725D1 (de) Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors
ATE202931T1 (de) Taxanderivate enthaltende arzneizubereitungen
BRPI0410488A (pt) composição farmacêutica lìquida estabilizada livre de hsa, método para preparação de composição farmacêutica lìquida estabilizada livre de hsa, recipiente vedado hermeticamente e kit para administração de múltiplas doses de composição farmacêutica lìquida estabilizada livre de hsa'
PE20030098A1 (es) Capsulas elasticas blandas y composiciones de las mismas
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
BRPI0418070A (pt) composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais
AR040441A1 (es) Compuesto de tiol, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento, procedimiento para prepararlo y compuesto intermediario de utilidad en dicho procedimiento
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.

Legal Events

Date Code Title Description
FC Refusal